Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV−2) causes coronavirus disease 2019 (COVID−19). Antibodies induced by SARS-CoV−2 infection or vaccination play pivotal roles in the body’s defense against the virus; many monoclonal antibodies (mAbs) against SARS-CoV−2 have been cloned, and so...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Minoru, Aoyama, Michihiko, Ishii-Watabe, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266124/
https://www.ncbi.nlm.nih.gov/pubmed/37309192
http://dx.doi.org/10.1080/19420862.2023.2222874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266124/
https://www.ncbi.nlm.nih.gov/pubmed/37309192
http://dx.doi.org/10.1080/19420862.2023.2222874

Ejemplares similares